The Pennant Group, Inc.
PNTG Healthcare Medical Care Facilities
The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.8%, EPS grew 23.8%, free cash flow fell 50.9% and total debt rose 433.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow PNTG
The Pennant Group, Inc. (PNTG) EV/Sales
As of 16 October 2026, The Pennant Group, Inc. (PNTG) trades at a EV/Sales of 1.5×. Over the past ten years it has ranged from 0.7× (October 2022) to 4.8× (January 2021); the current reading is higher than 59% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.2× | (22.74%) |
| FY2024 | 1.5× | 68.73% |
| FY2023 | 0.9× | 10.74% |
| FY2022 | 0.8× | (49.43%) |
| FY2021 | 1.6× | (61.31%) |
| FY2020 | 4.2× | 50.21% |
| FY2019 | 2.8× | 36.85% |
| FY2018 | 2.1× | 0.00% |
| FY2017 | 2.1× | 0.00% |
| FY2016 | 2.1× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.3× | 11.57% |
| Mar 2026 | 1.2× | 0.28% |
| Dec 2025 | 1.2× | 10.68% |
| Sep 2025 | 1.1× | (19.55%) |
| 27 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CMPS COMPASS Pathways PLC Sponsored ADR compare | n/m |
| AGL Agilon Health, Inc. compare | 0.2× |
| ARDT Ardent Health, Inc. compare | 0.3× |
| AMN AMN Healthcare Services Inc compare | 0.6× |
| HCSG Healthcare Services Group, Inc. compare | 0.7× |
| PNTG The Pennant Group, Inc. | 1.5× |
| NUTX Nutex Health Inc. compare | 1.6× |
| USPH U.S. Physical Therapy, Inc. compare | 1.8× |
| SNDA Sonida Senior Living, Inc. compare | 6.0× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)